Neuraminidase pharmacophore model derived from diverse classes of inhibitors

A quantitative pharmacophore hypothesis for AIV neuraminidase inhibitors was built based on 22 compounds with great molecular diversity and bioactivity, and validated using 88 compounds to be highly predictive.